Elizabeth H. Cull - Publications

Feasibility and Clinical Utility of Patient-Reported Outcome Measurement Information System-29 in a Newly Established Adolescent and Young Adult Oncology Program.

Journal: Journal of adolescent and young adult oncology

Published: July 03, 2024

ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.

Journal: Targeted oncology

Published: March 10, 2024

Structural and Ultrastructural Analysis of the Multiple Myeloma Cell Niche and a Patient-Specific Model of Plasma Cell Dysfunction.

Journal: Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada

Published: December 09, 2021

Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma.

Journal: Leukemia & lymphoma

Published: December 06, 2021

Post-hoc Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMA.

Journal: Frontiers in oncology

Published: October 31, 2021

Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436.

Journal: Cancers

Published: September 16, 2021

A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome.

Journal: Cancers

Published: July 20, 2021

A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers.

Journal: The oncologist

Published: March 05, 2021

Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype.

Journal: Nature reviews. Cardiology

Published: September 18, 2019

Politics trumps policy: How health ministers make decisions.

Journal: Healthcare management forum

Published: December 15, 2015

Clinical Use of Anti-Xa Monitoring in Malignancy-Associated Thrombosis.

Journal: Thrombosis

Published: July 16, 2015

The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years.

Journal: Best practice & research. Clinical haematology

Published: June 08, 2014